Current Drug Targets
Title:Editorial [Hot Topic: Small Molecules of Natural Origin for Cancer Therapy and Chemoprevention Part II: Pharmacogenomics and Biotechnological Applications of Small Molecules of Natural Origin for Cancer Therapy and Chemoprevention]
Volume: 7 Issue: 4
Author(s): Thomas Efferth
Affiliation:
Export Options
About this article
Cite this article as:
Efferth Thomas, Editorial [Hot Topic: Small Molecules of Natural Origin for Cancer Therapy and Chemoprevention Part II: Pharmacogenomics and Biotechnological Applications of Small Molecules of Natural Origin for Cancer Therapy and Chemoprevention], Current Drug Targets 2006; 7 (4) . https://dx.doi.org/10.2174/138945006776359386
DOI https://dx.doi.org/10.2174/138945006776359386 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Botulinum Toxin a in Prostate Disease: A Venom from Bench to Bed-Side
Current Drug Delivery Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis
Current Pharmaceutical Design Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: Molecular Mechanisms of Action
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) The Role of Integrin-Mediated Cell Adhesion in Atherosclerosis: Pathophysiology and Clinical Opportunities
Current Pharmaceutical Design Nuclear Factor Erythroid 2 - Related Factor 2 Signaling in Parkinson Disease: A Promising Multi Therapeutic Target Against Oxidative Stress, Neuroinflammation and Cell Death
CNS & Neurological Disorders - Drug Targets Role of microRNAs in Chronic Lymphocytic Leukemia Pathogenesis
Current Medicinal Chemistry Editorial [Hot topic:Metal-Containing Drugs and Novel Coordination Complexes in Therapeutic Anticancer Applications – Part I (Guest Editor: Irena Kostova)]
Anti-Cancer Agents in Medicinal Chemistry Autotaxin Inhibition: Challenges and Progress Toward Novel Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Biomarker Discovery and Translation in Metabolomics
Current Metabolomics Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery
Current Drug Metabolism Polymeric Nanomaterials as Nanomembrane Entities for Biomolecule and Drug Delivery
Current Pharmaceutical Design Study of 5-Fluorouracil Loaded Chitosan Nanoparticles for Treatment of Skin Cancer
Recent Patents on Nanotechnology Dietary Management of Gestational Diabetes Mellitus
Current Nutrition & Food Science Activin Receptor-Like Kinases: Structure, Function and Clinical Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets Protein Tyrosine Phosphatases, New Targets for Cancer Therapy
Current Cancer Drug Targets Microcirculation in Sepsis: New Perspectives
Current Vascular Pharmacology Advances on Cyclin-dependent Kinases (CDKs) as Novel Targets for Antiviral Drugs
Current Drug Targets - Infectious Disorders Targeting CFTR: How to Treat Cystic Fibrosis by CFTR-Repairing Therapies
Current Drug Targets Pharmacological Approaches to Chronic Spinal Cord Injury
Current Pharmaceutical Design